共 50 条
- [22] Transparency of Regulatory Data across the European Medicines Agency, Health Canada, and US Food and Drug Administration JOURNAL OF LAW MEDICINE & ETHICS, 2021, 49 (03): : 456 - 485
- [23] Blueprint for Transparency at the US Food and Drug Administration: Recommendations to Advance the Development of Safe and Effective Medical Products JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 7 - 23
- [24] The US’ Food and Drug Administration, Normativity of Risk Assessment, GMOs, and American Democracy Journal of Agricultural and Environmental Ethics, 2009, 22 : 125 - 139
- [25] The US' Food and Drug Administration, Normativity of Risk Assessment, GMOs, and American Democracy JOURNAL OF AGRICULTURAL & ENVIRONMENTAL ETHICS, 2009, 22 (02): : 125 - 139
- [26] Surgical Innovation and the US Food and Drug Administration FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2019, 25 (04): : 263 - 264
- [28] The US Food and Drug Administration and Emergency Contraception INTERNATIONAL JOURNAL OF PHARMACEUTICAL MEDICINE, 2005, 19 (03): : 139 - 140
- [29] Crisis deepens at the US Food and Drug Administration BRITISH MEDICAL JOURNAL, 2004, 329 (7478): : 1308 - 1308
- [30] US Food and Drug Administration gets it right BRITISH MEDICAL JOURNAL, 2002, 325 (7367): : 776 - 776